AGENCIES: Canadian and American researchers para koikena janaishe tai khan ekta antiviral drug olaishe koikena aro tai khan koikena janaishe ki etu covid19 virus variants concern(VOC) nimete thakishe.
Vancouver-based University of British Columbia (UBC para koikena janaidishe Etu drug toh N-0385 “mataa toh Sars-CoV-2 virus toh bondh kuri ase human cells te ghussaidishe tai khan laga flavoured cell gateways paishe.
Etu study laga ekta pre print version toh etu nutun drug nimete website te olaishe journal BioRXiv para olaidiya thakishe.
François Jean, project lead aro professor UBC’s department of microbiology and immunology, te para koikena janaishe ki etu researchers para report kurishe ekta novel aro highly potent small-molecule drug N-0385 mataa toh olaishe etu toh ekta effective entry inhibitor ase etia tak.”
Tai para koikena janaishe researchers khan para etu nutun drug toh olaishe aro etu toh protective ase infection aro mortality nimete chuha te aro biswass thakishe N-0385 toh ekta potential ase viable joldi elach lobule ase etia olai thaka Sars-CoV-2 VOCs laga khilaaf te,”
Etu drug laga dikdaar toh B.117 and B.1.351 variants uporte pudishe etu toh akhe te UK aro south Africa te paishe.
Multiple institutes khan milikena thqakishe etu drug bonabole nimete etu bi Universite de Sherbrooke Quebec aro US-based Cornell University laga researchers khan ase.
Canada’s Chief Public Health Officer, Theresa Tam para koikena janaidiya thakishe Aro vocs khan toh etia jai thaka india laga coronavirus cases nimete thakishe aro tai khan etia ekta majority covid 19 cases ase Canada te.”
Tai para koikena may 14 te koikena janaidiya thakishe etu B.1.617 variant, etu te tintal etia laga defined sub-lineages, te chinishe nouta provinces aro territories khan te.
Add Comment